Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand.

Bunchai ChongmelaxmePochamana PhisalprapaRatree SawangjitPiyameth DilokthornsakulNathorn Chaiyakunapruk

Published in: PharmacoEconomics (2020)

A weight reduction program can prevent cirrhosis and HCC occurrences, and dominates all other treatment options. Pioglitazone and vitamin E demonstrated a trend towards decreasing the number of cirrhosis and HCC cases.

Keyphrases

body mass index
weight loss
physical activity
weight gain
body weight